Latest Breaking News On - Private securities - Page 3 : comparemela.com

Fastenal Company Announces Cash Dividend

10.04.2024 - Fastenal Company (Nasdaq:FAST) reported its board of directors declared a dividend of $0.39 per share to be paid in cash on May 23, 2024 to shareholders of record at the close of business on April 25, 2024. Except for share and per share .

Lang schwarzExchange commissionFastenal companyTotal dividends paidFastenal managed inventoryWhere industry meetsPrivate securitiesLitigation reform actFastenal stockFastenal chartAstenal kursAstenal aktie

Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024

Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEric donnenfeldCarl spanaMichael raizmanSecurities exchangePrnewswire palatin technologies incAmerican society of cataractSymptom endpoints including the coPalatin technologies incPositive phaseResults includedPrimary symptom endpointPain met statistical significanceWeek treatment periodMultiple symptom endpointsCo primary pain endpoint

Usio, Inc (NASDAQ:USIO) Q4 2023 Earnings Call Transcript

Usio, Inc. beats earnings expectations. Reported EPS is $0.00098, expectations were $.

Los angeles countyUnited statesNew yorkPaul manleyLouis hochMichael longJon hickmanGreg carterMichael whiteScott buckMost elite us military specialLadenburg thalmannUsio incCall transcript marchUsio fourth quarterFiscal year end

SEC Roll-Out Of Climate Disclosure Rules Put On Hold Pending Ongoing Legal Challenges – What Does It Mean For SEC Filers? - Climate Change

Ending two years of anticipation over the final contours of its controversial foray into requiring a sweeping range of public company disclosures of business risks associated with climate change.

Exchange commissionCircuit courtFifth circuit courtFifth circuitAttorneys generalClimate related disclosuresSecurities actExchange actPrivate securitiesLitigation reform

Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting

29.02.2024 - Preclinical Research on Full-Thickness Cutaneous Wound Healing KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) - Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing .

Amina el ayadiHeather rainesUniversity of texas medical branch at galvestonExchange commissionDepartment of surgeryProvectus biopharmaceuticals incDivision of surgical sciencesNational institutes of healthSecurities exchangeAssistant professorSurgical sciencesTexas medical branchNational institutesPrivate securitiesLitigation reform actSecurities act